Abionic

18/12/2023

Healthcare providers, emergency care givers and all point of care facilities must make it a priority to detect sepsis early in order to save lives. There is a growing body of evidence that supports the use of biomarker detection, in particular, Pancreatic Stone Protein (PSP).

27/11/2023

The ACEM ASM 2023 last week demonstrated an array of technologies, techniques and concepts that enable professional teams to deliver exceptional patient care under pressure. The Abionic abioSCOPE 2.0 analyser is one such solution, changing the game when it comes to early sepsis detection.

Delegates visiting our stand were keen to find out about how the device provides a positive indication for sepsis up to 72 hours earlier than the current standard of care. Early diagnosis is key to good patient outcomes – every hour sepsis detection is delayed, survival rates decrease by 8%.

If you missed the team at the conference or want to know more about how you could revolutionise your point of care sepsis testing, visit https://au.getzhealthcare.com/products/medical-hospital/point-of-care-diagnostic-devices/abioScope%C2%AE-2.0/abioSCOPE-2.0.

10/11/2023

ACEM 38th Annual Scientific Meeting

21/09/2023